Estrogen activates migration potential of endometrial cancer cells through basement membrane

Tumor Biology

Volumn 17, Issue 1, 1996, Pages 48-57

  Fujimoto, Jiro ^a   Hori, Masashi ^a   Ichigo, Satoshi ^a   Morishita, Shigeo ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiestrogen; Basement membrane; Endometrial cancer; Estrogen; Invasiveness

Indexed keywords

DANAZOL; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; TAMOXIFEN;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029655360     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000217966     Document Type: Article

References (22)

1. Nisker J A, Ramzy I, Collins J A: Adenocarcinoma of the endometrium and abnormal ovarian function in young women. Am J Obstet Gynecol 1978;130:9-13.
2. Lippman ME. Swain SM: Endocrine-responsive cancers of human: in Wilson JD. Foster DW (eds): Textbook of Endocrinology, ed 8. Philadelphia. Saunders, 1992, pp 1577-1598.
3. Blasschuk OW, Farookhi R: Estradiol stimulates cadherin expression in rat granulosa cells. Dev Biol 1989: 136:564-567.
4. Choi YS, Schgal R, McCrea P, Gumbinder B: A cadherin-like protein in eggs and cleaving embryos of Xenopus laevisis expressed in oocytes in response to progesterone. J Cell Biol 1990:110:1575-1582.
5. Folkman J: Angiostatic steroids. Ann Surg 1987;206:374-383.
6. Fujimoto J, Fujita H, Hosoda S, Okada H: Effect of medroxyprogesterone acetate on secondary spreading of endometrial cancers. Invasion Metastasis 1989;9:209-215.
7. Fujimoto J, Hosoda S, Fujita H, Okada H: Inhibition of tumor angio-genesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. Invasion Metastasis 1989:9:269-277.
8. Jikihara H. Tcrada N, Yamamoto R, Nishikawa Y, Tanizawa O. Mat-sumoto K, Terakawa N: Inhibitory effect of medroxyprogesterone acetate on angiogcnesis induced by human endometrial cancer. Am J Ob-stet Gynecol 1992;167:207-211.
9. Nishida M, Kasahara K, Kaneko M, Iwasaki H: Establishment of a new human endometrial adenocarcinoma cell line. Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet Gynecol Jpn 1985: 37:1103-1110.
10. Ishiwata I, Ishiwata C: Effect of estradiol- 17 p and progesterone on cell proliferation and differentiation of the human endometrial carcinoma cell line (HHUA) in vitro. Asia Oceania J Obstet Gynaecol 1984:10: 531-538.
11. Kleinman HK, McGarvey ML, Hassell JR. Star VL. Cannon FB, Laurie GW: Basement membrane complexes with biological activity. Biochemistry 1986;25:312-318.
12. Burton K: A study of the conditions and mechanisms of the diphenyla-mine reaction for the colorimetric estimation of deoxyribonucleic acid. J Biochcm 1956;62:315-323.
13. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-254.
14. Scatchard G: The attraction of proteins for small molecules and irons. Ann NY Acad Sci 1979:51:660-672.
15. Wooley DE: Collagenolytic mechanism in tumor cell invasion. Cancer Metastasis Rev 1984:3:361-372.
16. Sloane BF: Cathepsin B and cysta-tins: Evidence for a role in cancer progression. Semin Cancer Biol 1990;1:137-152.
17. Kane SE, Gottesman MM: The role of cathepsin L in malignant transformation. Semin Cancer Biol 1990;1: 127-136.
18. Rochefort H: Biological and clinical significance of cathepsin D in breast cancer. Semin Cancer Biol 1990; 1: 153-160.
19. Nakajima M, Irimura T, Nicolson GL: Heparanases and tumor metastasis. J Cell Biochem 1988:36:157-167.
20. Blasi F, Verde P: Urokinase-dependent cell surface proteolysis and cancer. Semin Cancer Biol 1990:1:117-126.
21. Schatz F, Lockwood CJ: Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells. J Clin Endocrinol Metab 1993: 77:621-625.
22. Tamaya T, Wada K. Mori H, Imai A: Different effects on estrogen binding sites and anti-estrogenic action of danazol and progesterone. Ann Clin Biochem 1991;28:250-252.